Skip to content

Anna Vanderhoff

NPI 1659812907ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Seattle, WA

Obstetrics & Gynecology, Reproductive Endocrinology in Seattle, Washington, licensed in WA, with an NPI issued in March 2017. Ferring Pharmaceuticals Inc. reported $16.69 in payments in 2025, mostly food and beverage.

Overview

NPI1659812907
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedMar 19, 2017
Last updated in NPPESJun 12, 2026
Certified by providerJun 12, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Obstetrics & Gynecology, Reproductive Endocrinology Primary207VE0102XMD.MD.61579189WA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$16.69 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$16.691

What the 2025 payments were for

  • Food and Beverage$16.69 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Seattle

All 17 Obstetrics & Gynecology, Reproductive Endocrinology providers in Seattle · All Obstetrics & Gynecology, Reproductive Endocrinology providers in Washington